CHOLANGIOCARCINOMA, HILAR
Clinical trials for CHOLANGIOCARCINOMA, HILAR explained in plain language.
Never miss a new study
Get alerted when new CHOLANGIOCARCINOMA, HILAR trials appear
Sign up with your email to follow new studies for CHOLANGIOCARCINOMA, HILAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood tests and patient surveys could improve bile duct cancer monitoring
Knowledge-focused Not yet recruitingThis study aims to learn if blood tests for cancer DNA (ctDNA) and patient-reported quality of life can help doctors predict how bile duct cancer will progress and whether treatments are working. Researchers will collect blood samples and surveys from 300 patients with curable or…
Matched conditions: CHOLANGIOCARCINOMA, HILAR
Sponsor: Aarhus University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Does removing blood vessels boost survival in bile duct cancer surgery?
Knowledge-focused Not yet recruitingThis study reviews past medical records of 300 people who had surgery for a rare and aggressive bile duct cancer called hilar cholangiocarcinoma. It aims to see if also removing nearby blood vessels during the operation helps patients live longer and have fewer complications. The…
Matched conditions: CHOLANGIOCARCINOMA, HILAR
Sponsor: Yongjun Chen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
New study tests smaller liver surgery for tough bile duct cancers
Knowledge-focused Not yet recruitingThis study looks at a type of liver surgery called volume-restricted resection for patients with a rare bile duct cancer (perihilar cholangiocarcinoma) whose liver is too small after standard surgery. Researchers will follow 300 patients who get this surgery or non-surgical care …
Matched conditions: CHOLANGIOCARCINOMA, HILAR
Sponsor: Yongjun Chen • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:15 UTC